Ontology type: schema:ScholarlyArticle
2021-10-26
AUTHORSDavid J. Sanders, Kousik Krishnan
ABSTRACTPurpose of ReviewHis bundle pacing (HBP) and left bundle branch pacing (LBBP) offer physiologic activation of the conduction system and their use is expanding. But choosing the best modality for an individual clinical scenario remains challenging. We review the evidence supporting HBP, LBBP, and traditional biventricular cardiac resynchronization therapy (BiV CRT), and relate this to appropriate patient selection.Recent FindingsTraditional BiV CRT has been established as effective in certain patients but is limited by a high rate of non-response. More precise ECG analysis and prognostic models that incorporate echocardiographic and clinical parameters will help predict which patients will respond to therapy. HBP has been shown to be safe and feasible for a range of bradyarrhythmias and as an alternative to BiV CRT. Short-term clinical outcomes are promising. This modality is limited, however, by its technically challenging implant, inability to correct distal conduction system disease, and occasionally high pacing thresholds. LBBP was developed to bypass some of HBP’s shortcomings. It too has been shown to be safe and feasible, while lead implant is technically easier and pacing is effective at low thresholds. Clinical outcomes with LBBP have yet to be examined.SummaryTraditional BiV CRT remains an important pacing technique for patients with systolic dysfunction and more detailed prognostic models will refine patient selection. HBP and LBBP show great potential for the spectrum of pacing indications and their use will likely expand as data on clinical outcomes accumulate. More... »
PAGES22
http://scigraph.springernature.com/pub.10.1007/s12170-021-00684-6
DOIhttp://dx.doi.org/10.1007/s12170-021-00684-6
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1142190138
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Department of Internal Medicine, Division of Cardiology, Rush University Medical Center, 1725 W. Harrison St. Suite 1159, 60612, Chicago, IL, USA",
"id": "http://www.grid.ac/institutes/grid.240684.c",
"name": [
"Department of Internal Medicine, Division of Cardiology, Rush University Medical Center, 1725 W. Harrison St. Suite 1159, 60612, Chicago, IL, USA"
],
"type": "Organization"
},
"familyName": "Sanders",
"givenName": "David J.",
"type": "Person"
},
{
"affiliation": {
"alternateName": "Midwest Cardiovascular Institute, 801 S Washington St 4th Floor, 60540, Naperville, IL, USA",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Internal Medicine, Division of Cardiology, Section of Cardiac Electrophysiology, Rush University Medical Center, 1725 W. Harrison St. Suite 1159, 60612, Chicago, IL, USA",
"Midwest Cardiovascular Institute, 801 S Washington St 4th Floor, 60540, Naperville, IL, USA"
],
"type": "Organization"
},
"familyName": "Krishnan",
"givenName": "Kousik",
"id": "sg:person.01034174101.03",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034174101.03"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s00276-004-0302-7",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1025271308",
"https://doi.org/10.1007/s00276-004-0302-7"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10554-015-0607-0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1017086225",
"https://doi.org/10.1007/s10554-015-0607-0"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s003920170053",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022023931",
"https://doi.org/10.1007/s003920170053"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nrcardio.2014.67",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009501331",
"https://doi.org/10.1038/nrcardio.2014.67"
],
"type": "CreativeWork"
}
],
"datePublished": "2021-10-26",
"datePublishedReg": "2021-10-26",
"description": "Purpose of ReviewHis bundle pacing (HBP) and left bundle branch pacing (LBBP) offer physiologic activation of the conduction system and their use is expanding. But choosing the best modality for an individual clinical scenario remains challenging. We review the evidence supporting HBP, LBBP, and traditional biventricular cardiac resynchronization therapy (BiV CRT), and relate this to appropriate patient selection.Recent FindingsTraditional BiV CRT has been established as effective in certain patients but is limited by a high rate of non-response. More precise ECG analysis and prognostic models that incorporate echocardiographic and clinical parameters will help predict which patients will respond to therapy. HBP has been shown to be safe and feasible for a range of bradyarrhythmias and as an alternative to BiV CRT. Short-term clinical outcomes are promising. This modality is limited, however, by its technically challenging implant, inability to correct distal conduction system disease, and occasionally high pacing thresholds. LBBP was developed to bypass some of HBP\u2019s shortcomings. It too has been shown to be safe and feasible, while lead implant is technically easier and pacing is effective at low thresholds. Clinical outcomes with LBBP have yet to be examined.SummaryTraditional BiV CRT remains an important pacing technique for patients with systolic dysfunction and more detailed prognostic models will refine patient selection. HBP and LBBP show great potential for the spectrum of pacing indications and their use will likely expand as data on clinical outcomes accumulate.",
"genre": "article",
"id": "sg:pub.10.1007/s12170-021-00684-6",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1039476",
"issn": [
"1932-9520",
"1932-9563"
],
"name": "Current Cardiovascular Risk Reports",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "11",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "15"
}
],
"keywords": [
"biventricular cardiac resynchronization therapy",
"cardiac resynchronization therapy",
"bundle branch pacing",
"clinical outcomes",
"patient selection",
"BiV-CRT",
"resynchronization therapy",
"prognostic model",
"short-term clinical outcomes",
"individual clinical scenarios",
"conduction system disease",
"high pacing threshold",
"systolic dysfunction",
"clinical parameters",
"certain patients",
"best modality",
"bundle pacing",
"system diseases",
"pacing threshold",
"clinical scenarios",
"pacing techniques",
"LBBP",
"conduction system",
"patients",
"physiologic activation",
"therapy",
"pacing",
"high rate",
"outcomes",
"low threshold",
"modalities",
"HBP",
"CRT",
"bradyarrhythmias",
"dysfunction",
"ECG analysis",
"disease",
"activation",
"indications",
"use",
"threshold",
"evidence",
"inability",
"rate",
"bundles",
"purpose",
"selection",
"data",
"alternative",
"potential",
"analysis",
"model",
"great potential",
"technique",
"parameters",
"system",
"range",
"shortcomings",
"spectra",
"scenarios"
],
"name": "Patient Selection for Biventricular Cardiac Resynchronization Therapy, His Bundle Pacing, and Left Bundle Branch Pacing",
"pagination": "22",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1142190138"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/s12170-021-00684-6"
]
}
],
"sameAs": [
"https://doi.org/10.1007/s12170-021-00684-6",
"https://app.dimensions.ai/details/publication/pub.1142190138"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-20T07:38",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_876.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/s12170-021-00684-6"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00684-6'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00684-6'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00684-6'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12170-021-00684-6'
This table displays all metadata directly associated to this object as RDF triples.
144 TRIPLES
22 PREDICATES
89 URIs
77 LITERALS
6 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1007/s12170-021-00684-6 | schema:about | anzsrc-for:11 |
2 | ″ | ″ | anzsrc-for:1103 |
3 | ″ | schema:author | N78e8c2c2e08948b5a037443ebcebac75 |
4 | ″ | schema:citation | sg:pub.10.1007/s00276-004-0302-7 |
5 | ″ | ″ | sg:pub.10.1007/s003920170053 |
6 | ″ | ″ | sg:pub.10.1007/s10554-015-0607-0 |
7 | ″ | ″ | sg:pub.10.1038/nrcardio.2014.67 |
8 | ″ | schema:datePublished | 2021-10-26 |
9 | ″ | schema:datePublishedReg | 2021-10-26 |
10 | ″ | schema:description | Purpose of ReviewHis bundle pacing (HBP) and left bundle branch pacing (LBBP) offer physiologic activation of the conduction system and their use is expanding. But choosing the best modality for an individual clinical scenario remains challenging. We review the evidence supporting HBP, LBBP, and traditional biventricular cardiac resynchronization therapy (BiV CRT), and relate this to appropriate patient selection.Recent FindingsTraditional BiV CRT has been established as effective in certain patients but is limited by a high rate of non-response. More precise ECG analysis and prognostic models that incorporate echocardiographic and clinical parameters will help predict which patients will respond to therapy. HBP has been shown to be safe and feasible for a range of bradyarrhythmias and as an alternative to BiV CRT. Short-term clinical outcomes are promising. This modality is limited, however, by its technically challenging implant, inability to correct distal conduction system disease, and occasionally high pacing thresholds. LBBP was developed to bypass some of HBP’s shortcomings. It too has been shown to be safe and feasible, while lead implant is technically easier and pacing is effective at low thresholds. Clinical outcomes with LBBP have yet to be examined.SummaryTraditional BiV CRT remains an important pacing technique for patients with systolic dysfunction and more detailed prognostic models will refine patient selection. HBP and LBBP show great potential for the spectrum of pacing indications and their use will likely expand as data on clinical outcomes accumulate. |
11 | ″ | schema:genre | article |
12 | ″ | schema:inLanguage | en |
13 | ″ | schema:isAccessibleForFree | false |
14 | ″ | schema:isPartOf | N32d99f501f89409d96e50a528a3e839c |
15 | ″ | ″ | N6df14f2d63f04a67a5cb27062d3b05c3 |
16 | ″ | ″ | sg:journal.1039476 |
17 | ″ | schema:keywords | BiV-CRT |
18 | ″ | ″ | CRT |
19 | ″ | ″ | ECG analysis |
20 | ″ | ″ | HBP |
21 | ″ | ″ | LBBP |
22 | ″ | ″ | activation |
23 | ″ | ″ | alternative |
24 | ″ | ″ | analysis |
25 | ″ | ″ | best modality |
26 | ″ | ″ | biventricular cardiac resynchronization therapy |
27 | ″ | ″ | bradyarrhythmias |
28 | ″ | ″ | bundle branch pacing |
29 | ″ | ″ | bundle pacing |
30 | ″ | ″ | bundles |
31 | ″ | ″ | cardiac resynchronization therapy |
32 | ″ | ″ | certain patients |
33 | ″ | ″ | clinical outcomes |
34 | ″ | ″ | clinical parameters |
35 | ″ | ″ | clinical scenarios |
36 | ″ | ″ | conduction system |
37 | ″ | ″ | conduction system disease |
38 | ″ | ″ | data |
39 | ″ | ″ | disease |
40 | ″ | ″ | dysfunction |
41 | ″ | ″ | evidence |
42 | ″ | ″ | great potential |
43 | ″ | ″ | high pacing threshold |
44 | ″ | ″ | high rate |
45 | ″ | ″ | inability |
46 | ″ | ″ | indications |
47 | ″ | ″ | individual clinical scenarios |
48 | ″ | ″ | low threshold |
49 | ″ | ″ | modalities |
50 | ″ | ″ | model |
51 | ″ | ″ | outcomes |
52 | ″ | ″ | pacing |
53 | ″ | ″ | pacing techniques |
54 | ″ | ″ | pacing threshold |
55 | ″ | ″ | parameters |
56 | ″ | ″ | patient selection |
57 | ″ | ″ | patients |
58 | ″ | ″ | physiologic activation |
59 | ″ | ″ | potential |
60 | ″ | ″ | prognostic model |
61 | ″ | ″ | purpose |
62 | ″ | ″ | range |
63 | ″ | ″ | rate |
64 | ″ | ″ | resynchronization therapy |
65 | ″ | ″ | scenarios |
66 | ″ | ″ | selection |
67 | ″ | ″ | short-term clinical outcomes |
68 | ″ | ″ | shortcomings |
69 | ″ | ″ | spectra |
70 | ″ | ″ | system |
71 | ″ | ″ | system diseases |
72 | ″ | ″ | systolic dysfunction |
73 | ″ | ″ | technique |
74 | ″ | ″ | therapy |
75 | ″ | ″ | threshold |
76 | ″ | ″ | use |
77 | ″ | schema:name | Patient Selection for Biventricular Cardiac Resynchronization Therapy, His Bundle Pacing, and Left Bundle Branch Pacing |
78 | ″ | schema:pagination | 22 |
79 | ″ | schema:productId | N3dfb6ea5f15446d48008f9831910b0c8 |
80 | ″ | ″ | N77eb4d3e6c1f42b5946aae799fa48e23 |
81 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1142190138 |
82 | ″ | ″ | https://doi.org/10.1007/s12170-021-00684-6 |
83 | ″ | schema:sdDatePublished | 2022-05-20T07:38 |
84 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
85 | ″ | schema:sdPublisher | Nd0c4c0a7e09a4fed9f653ae824305c20 |
86 | ″ | schema:url | https://doi.org/10.1007/s12170-021-00684-6 |
87 | ″ | sgo:license | sg:explorer/license/ |
88 | ″ | sgo:sdDataset | articles |
89 | ″ | rdf:type | schema:ScholarlyArticle |
90 | N32d99f501f89409d96e50a528a3e839c | schema:issueNumber | 11 |
91 | ″ | rdf:type | schema:PublicationIssue |
92 | N3dfb6ea5f15446d48008f9831910b0c8 | schema:name | doi |
93 | ″ | schema:value | 10.1007/s12170-021-00684-6 |
94 | ″ | rdf:type | schema:PropertyValue |
95 | N6df14f2d63f04a67a5cb27062d3b05c3 | schema:volumeNumber | 15 |
96 | ″ | rdf:type | schema:PublicationVolume |
97 | N77eb4d3e6c1f42b5946aae799fa48e23 | schema:name | dimensions_id |
98 | ″ | schema:value | pub.1142190138 |
99 | ″ | rdf:type | schema:PropertyValue |
100 | N78e8c2c2e08948b5a037443ebcebac75 | rdf:first | N7bf24cac18764bcc959bca2afda66060 |
101 | ″ | rdf:rest | N9a8770f0cca4445aa414dda571aa4353 |
102 | N7bf24cac18764bcc959bca2afda66060 | schema:affiliation | grid-institutes:grid.240684.c |
103 | ″ | schema:familyName | Sanders |
104 | ″ | schema:givenName | David J. |
105 | ″ | rdf:type | schema:Person |
106 | N9a8770f0cca4445aa414dda571aa4353 | rdf:first | sg:person.01034174101.03 |
107 | ″ | rdf:rest | rdf:nil |
108 | Nd0c4c0a7e09a4fed9f653ae824305c20 | schema:name | Springer Nature - SN SciGraph project |
109 | ″ | rdf:type | schema:Organization |
110 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
111 | ″ | schema:name | Medical and Health Sciences |
112 | ″ | rdf:type | schema:DefinedTerm |
113 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
114 | ″ | schema:name | Clinical Sciences |
115 | ″ | rdf:type | schema:DefinedTerm |
116 | sg:journal.1039476 | schema:issn | 1932-9520 |
117 | ″ | ″ | 1932-9563 |
118 | ″ | schema:name | Current Cardiovascular Risk Reports |
119 | ″ | schema:publisher | Springer Nature |
120 | ″ | rdf:type | schema:Periodical |
121 | sg:person.01034174101.03 | schema:affiliation | grid-institutes:None |
122 | ″ | schema:familyName | Krishnan |
123 | ″ | schema:givenName | Kousik |
124 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01034174101.03 |
125 | ″ | rdf:type | schema:Person |
126 | sg:pub.10.1007/s00276-004-0302-7 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1025271308 |
127 | ″ | ″ | https://doi.org/10.1007/s00276-004-0302-7 |
128 | ″ | rdf:type | schema:CreativeWork |
129 | sg:pub.10.1007/s003920170053 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1022023931 |
130 | ″ | ″ | https://doi.org/10.1007/s003920170053 |
131 | ″ | rdf:type | schema:CreativeWork |
132 | sg:pub.10.1007/s10554-015-0607-0 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1017086225 |
133 | ″ | ″ | https://doi.org/10.1007/s10554-015-0607-0 |
134 | ″ | rdf:type | schema:CreativeWork |
135 | sg:pub.10.1038/nrcardio.2014.67 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1009501331 |
136 | ″ | ″ | https://doi.org/10.1038/nrcardio.2014.67 |
137 | ″ | rdf:type | schema:CreativeWork |
138 | grid-institutes:None | schema:alternateName | Midwest Cardiovascular Institute, 801 S Washington St 4th Floor, 60540, Naperville, IL, USA |
139 | ″ | schema:name | Department of Internal Medicine, Division of Cardiology, Section of Cardiac Electrophysiology, Rush University Medical Center, 1725 W. Harrison St. Suite 1159, 60612, Chicago, IL, USA |
140 | ″ | ″ | Midwest Cardiovascular Institute, 801 S Washington St 4th Floor, 60540, Naperville, IL, USA |
141 | ″ | rdf:type | schema:Organization |
142 | grid-institutes:grid.240684.c | schema:alternateName | Department of Internal Medicine, Division of Cardiology, Rush University Medical Center, 1725 W. Harrison St. Suite 1159, 60612, Chicago, IL, USA |
143 | ″ | schema:name | Department of Internal Medicine, Division of Cardiology, Rush University Medical Center, 1725 W. Harrison St. Suite 1159, 60612, Chicago, IL, USA |
144 | ″ | rdf:type | schema:Organization |